September 26, 2017 4:44 AM ET

Pharmaceuticals

Company Overview of Knoll SpA

Company Overview

Knoll SpA detects pharmacological agents in the treatment of the main human diseases. The company started with products for treating cardiovascular disease, mainly through the synthesis of Verapamil. Thereafter the company started working on some other cardiac diseases, such as arrhythmia, hypertension and cardiac decompensation. The company focuses on areas such as obesity, depression, metabolic deficiencies, tissue repair, and throat. The company was founded in 1929 and is headquartered in Muggio', Italy.

Viale Europa, 35

Muggio',  20053

Italy

Founded in 1929

Phone:

39 39 24426

Fax:

39 39 795014

Key Executives for Knoll SpA

Medical Advisor of Cardiovascular Clinical Research
Compensation as of Fiscal Year 2017.

Similar Private Companies By Industry

Company Name Region
A. Menarini Industrie Farmaceutiche Riunite Srl Europe
Aboca S.p.A. - Societa Agricola Europe
ACME S.r.l. Europe
ACS Dobfar S.p.A. Europe
Agrisana S.R.L. Europe

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
NYC2012, Inc. United States
Tax Management Inc United States
Bertelsmann AG Europe

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Knoll SpA, please visit www.knoll-farma.it. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.